HDAC6-IN-25

HDAC6-IN-25, known as compound 8, is a potent and selective HDAC6 inhibitor with an IC50 of 0.6 nM. It is used in research to explore HDAC6's roles in cancer progression, neurodegenerative disorders, and immune regulation through both in vitro experiments and in vivo animal studies, as documented in public literature.